ANDEXXA: payments to doctors
Payments that named ANDEXXA as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $8.7M
- Providers
- 20,779
- Transactions
- 42,491
- Average per transaction
- $204
The per-transaction average — $204 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 20,779 providers the average total is $418, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| AstraZeneca | $6,071,180 | 70.0% |
| Portola Pharmaceuticals, Inc. | $1,291,694 | 14.9% |
| Portola Pharmaceuticals, LLC | $1,234,968 | 14.2% |
| Astrazeneca UK Limited | $39,620 | 0.5% |
| Astrazeneca AB | $38,154 | 0.4% |